Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial

Mario Berger; Aidan MacNamara; João Pedro Ferreira; Peter Kolkhof; Sebastian Voss; Adam Skubala; Andrea Scalise; Laura Goea; Richard Nkulikiyinka; Bertram Pitt; Joachim Hanno Ix; Peter Rossing; Richard John Mark Coward; Faiez Zannad; Hiddo J L Heerspink

doi:10.1093/eurheartj/ehaf316

Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial

Mario Berger^*, Aidan MacNamara, João Pedro Ferreira, Peter Kolkhof, Sebastian Voss, Adam Skubala, Andrea Scalise, Laura Goea, Richard Nkulikiyinka, Bertram Pitt, Joachim Hanno Ix, Peter Rossing, Richard John Mark Coward, Faiez Zannad, Hiddo J L Heerspink

^*Corresponding author for this work

Bristol Medical School (THS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

8 Citations (Scopus)

Abstract

[no abstract]

Original language	English
Article number	ehaf316
Pages (from-to)	3382-3386
Number of pages	5
Journal	European Heart Journal
Volume	46
Issue number	34
Early online date	26 May 2025
DOIs	https://doi.org/10.1093/eurheartj/ehaf316
Publication status	Published - 8 Sept 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology

Access to Document

10.1093/eurheartj/ehaf316Licence: CC BY

Handle.net

Persistent link

Cite this

Berger, M., MacNamara, A., Ferreira, J. P., Kolkhof, P., Voss, S., Skubala, A., Scalise, A., Goea, L., Nkulikiyinka, R., Pitt, B., Ix, J. H., Rossing, P., Coward, R. J. M., Zannad, F., & Heerspink, H. J. L. (2025). Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial. European Heart Journal, 46(34), 3382-3386. Article ehaf316. https://doi.org/10.1093/eurheartj/ehaf316

@article{4d54e75e5a544d458152348973bb320c,

title = "Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial",

abstract = "[no abstract]",

author = "Mario Berger and Aidan MacNamara and Ferreira, \{Jo{\~a}o Pedro\} and Peter Kolkhof and Sebastian Voss and Adam Skubala and Andrea Scalise and Laura Goea and Richard Nkulikiyinka and Bertram Pitt and Ix, \{Joachim Hanno\} and Peter Rossing and Coward, \{Richard John Mark\} and Faiez Zannad and Heerspink, \{Hiddo J L\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology",

year = "2025",

month = sep,

day = "8",

doi = "10.1093/eurheartj/ehaf316",

language = "English",

volume = "46",

pages = "3382--3386",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "34",

}

TY - JOUR

T1 - Finerenone effects on biomarkers

T2 - an analysis from the FIGARO-DKD trial

AU - Berger, Mario

AU - MacNamara, Aidan

AU - Ferreira, João Pedro

AU - Kolkhof, Peter

AU - Voss, Sebastian

AU - Skubala, Adam

AU - Scalise, Andrea

AU - Goea, Laura

AU - Nkulikiyinka, Richard

AU - Pitt, Bertram

AU - Ix, Joachim Hanno

AU - Rossing, Peter

AU - Coward, Richard John Mark

AU - Zannad, Faiez

AU - Heerspink, Hiddo J L

PY - 2025/9/8

Y1 - 2025/9/8

N2 - [no abstract]

AB - [no abstract]

U2 - 10.1093/eurheartj/ehaf316

DO - 10.1093/eurheartj/ehaf316

M3 - Article (Academic Journal)

C2 - 40415577

SN - 0195-668X

VL - 46

SP - 3382

EP - 3386

JO - European Heart Journal

JF - European Heart Journal

IS - 34

M1 - ehaf316

ER -